Recent developments and highlights in allergic rhinitis
© 2019 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd..
Allergic rhinitis (AR) is a disease with high prevalence all over the world and therefore needs to be thoroughly investigated and treated accordingly. The mechanisms underlying the pathology and treatment of AR have been widely studied, but many aspects remain unclear and warrant further investigations. This review presents an overview of recently published papers highlighting the risk factors, mechanisms, and treatment of AR. Additionally, recent studies discussing the role of single nucleotide polymorphism, DNA methylation, regulatory B cells, group 2 innate lymphoid cells, immunotherapy, and biologics in AR are also covered.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Allergy - 74(2019), 12 vom: 01. Dez., Seite 2320-2328 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Meng, Yifan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Allergic rhinitis |
|---|
| Anmerkungen: |
Date Completed 09.09.2020 Date Revised 09.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/all.14067 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301787042 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301787042 | ||
| 003 | DE-627 | ||
| 005 | 20231225105341.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.14067 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1005.xml |
| 035 | |a (DE-627)NLM301787042 | ||
| 035 | |a (NLM)31571226 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Meng, Yifan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent developments and highlights in allergic rhinitis |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.09.2020 | ||
| 500 | |a Date Revised 09.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd. | ||
| 520 | |a Allergic rhinitis (AR) is a disease with high prevalence all over the world and therefore needs to be thoroughly investigated and treated accordingly. The mechanisms underlying the pathology and treatment of AR have been widely studied, but many aspects remain unclear and warrant further investigations. This review presents an overview of recently published papers highlighting the risk factors, mechanisms, and treatment of AR. Additionally, recent studies discussing the role of single nucleotide polymorphism, DNA methylation, regulatory B cells, group 2 innate lymphoid cells, immunotherapy, and biologics in AR are also covered | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a allergic rhinitis | |
| 650 | 4 | |a biologics | |
| 650 | 4 | |a epigenetics | |
| 650 | 4 | |a risk factors | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Wang, Chengshuo |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Luo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d 1980 |g 74(2019), 12 vom: 01. Dez., Seite 2320-2328 |w (DE-627)NLM000313874 |x 1398-9995 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2019 |g number:12 |g day:01 |g month:12 |g pages:2320-2328 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.14067 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2019 |e 12 |b 01 |c 12 |h 2320-2328 | ||